| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from warrant exercise-Warrant Inducement | 8,760,519 | - |
| Proceeds from warrant exercise-Class HWarrants | 363,000 | - |
| Net cash provided by financing activities | 12,512,060 | 3,388,541 |
| Net increase (decrease) in cash and cash equivalents | 6,209,471 | -1,325,147 |
| Cash and cash equivalents at beginning of period | 6,499,018 | - |
| Cash and cash equivalents at end of period | 12,708,489 | - |
REVELATION BIOSCIENCES, INC. (REVBW)
REVELATION BIOSCIENCES, INC. (REVBW)